How Do Head and Neck Cancer Patients Prioritize Treatment Outcomes Before Initiating Treatment?

Marcy A List; John Stracks; Laura Colangelo; Pamela Butler; Natasha Ganzenko; Donna Lundy; Paula Sullivan; Daniel Haraf; Merrill Kies; William Goodwin; Everett E Vokes

doi:10.1200/JCO.2000.18.4.877

Back

How Do Head and Neck Cancer Patients Prioritize Treatment Outcomes Before Initiating Treatment?

Journal article

Peer reviewed

How Do Head and Neck Cancer Patients Prioritize Treatment Outcomes Before Initiating Treatment?

Marcy A List, John Stracks, Laura Colangelo, Pamela Butler, Natasha Ganzenko, Donna Lundy, Paula Sullivan, Daniel Haraf, Merrill Kies, William Goodwin, …

Journal of clinical oncology, Vol.18(4), pp.877-877

2000-02-14

DOI: https://doi.org/10.1200/JCO.2000.18.4.877

PMID: 10673531

Abstract

PURPOSE: To determine, pretreatment, how head and neck cancer (HNC) patients prioritize potential treatment effects in relationship to each other and to survival and to ascertain whether patients’ preferences are related to demographic or disease characteristics, performance status, or quality of life (QOL). PATIENTS AND METHODS: One hundred thirty-one patients were assessed pretreatment using standardized measures of QOL (Functional Assessment of Cancer Therapy-Head and Neck) and performance (Performance Status Scale for Head and Neck Cancer). Patients were also asked to rank a series of 12 potential HNC treatment effects. RESULTS: Being cured was ranked top priority by 75% of patients; another 18% ranked it second or third. Living as long as possible and having no pain were placed in the top three by 56% and 35% of patients, respectively. Items that were ranked in the top three by 10% to 24% of patients included those related to energy, swallowing, voice, and appearance. Items related to chewing, being understood, tasting, and dry mouth were placed in the top three by less than 10% of patients. Excluding the top three rankings, there was considerable variability in ratings. Rankings were generally unrelated to patient or disease characteristics, with the exception that cure and living were of slightly lower priority and pain of higher priority to older patients compared with younger patients. CONCLUSION: The data suggest that, at least pretreatment, survival is of primary importance to patients, supporting the development of aggressive treatment strategies. In addition, results highlight individual variability and warn against making assumptions about patients’ attitudes vis-à-vis potential outcomes. Whether patients’ priorities will change as they experience late effects is currently under investigation.

Metrics

22 Record Views

142 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.179 Oncology; 1.179.377 Head And Neck Cancer
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: How Do Head and Neck Cancer Patients Prioritize Treatment Outcomes Before Initiating Treatment?
Creators: Marcy A List - From the Departments of Medicine and Radiation and Cellular Oncologyand the Cancer Research Center, University of Chicago; Chicago Oral Cancer Center; Lurie Cancer Center Biostatistics Section, Health Services Research and Policy Studies, and Northwestern University Medical School, Northwestern University, Chicago, IL; and University of Miami, Miami, FL
John Stracks - From the Departments of Medicine and Radiation and Cellular Oncologyand the Cancer Research Center, University of Chicago; Chicago Oral Cancer Center; Lurie Cancer Center Biostatistics Section, Health Services Research and Policy Studies, and Northwestern University Medical School, Northwestern University, Chicago, IL; and University of Miami, Miami, FL
Laura Colangelo - From the Departments of Medicine and Radiation and Cellular Oncologyand the Cancer Research Center, University of Chicago; Chicago Oral Cancer Center; Lurie Cancer Center Biostatistics Section, Health Services Research and Policy Studies, and Northwestern University Medical School, Northwestern University, Chicago, IL; and University of Miami, Miami, FL
Pamela Butler - From the Departments of Medicine and Radiation and Cellular Oncologyand the Cancer Research Center, University of Chicago; Chicago Oral Cancer Center; Lurie Cancer Center Biostatistics Section, Health Services Research and Policy Studies, and Northwestern University Medical School, Northwestern University, Chicago, IL; and University of Miami, Miami, FL
Natasha Ganzenko - From the Departments of Medicine and Radiation and Cellular Oncologyand the Cancer Research Center, University of Chicago; Chicago Oral Cancer Center; Lurie Cancer Center Biostatistics Section, Health Services Research and Policy Studies, and Northwestern University Medical School, Northwestern University, Chicago, IL; and University of Miami, Miami, FL
Donna Lundy - From the Departments of Medicine and Radiation and Cellular Oncologyand the Cancer Research Center, University of Chicago; Chicago Oral Cancer Center; Lurie Cancer Center Biostatistics Section, Health Services Research and Policy Studies, and Northwestern University Medical School, Northwestern University, Chicago, IL; and University of Miami, Miami, FL
Paula Sullivan - From the Departments of Medicine and Radiation and Cellular Oncologyand the Cancer Research Center, University of Chicago; Chicago Oral Cancer Center; Lurie Cancer Center Biostatistics Section, Health Services Research and Policy Studies, and Northwestern University Medical School, Northwestern University, Chicago, IL; and University of Miami, Miami, FL
Daniel Haraf - From the Departments of Medicine and Radiation and Cellular Oncologyand the Cancer Research Center, University of Chicago; Chicago Oral Cancer Center; Lurie Cancer Center Biostatistics Section, Health Services Research and Policy Studies, and Northwestern University Medical School, Northwestern University, Chicago, IL; and University of Miami, Miami, FL
Merrill Kies - From the Departments of Medicine and Radiation and Cellular Oncologyand the Cancer Research Center, University of Chicago; Chicago Oral Cancer Center; Lurie Cancer Center Biostatistics Section, Health Services Research and Policy Studies, and Northwestern University Medical School, Northwestern University, Chicago, IL; and University of Miami, Miami, FL
William Goodwin - From the Departments of Medicine and Radiation and Cellular Oncologyand the Cancer Research Center, University of Chicago; Chicago Oral Cancer Center; Lurie Cancer Center Biostatistics Section, Health Services Research and Policy Studies, and Northwestern University Medical School, Northwestern University, Chicago, IL; and University of Miami, Miami, FL
Everett E Vokes - From the Departments of Medicine and Radiation and Cellular Oncologyand the Cancer Research Center, University of Chicago; Chicago Oral Cancer Center; Lurie Cancer Center Biostatistics Section, Health Services Research and Policy Studies, and Northwestern University Medical School, Northwestern University, Chicago, IL; and University of Miami, Miami, FL
Publication Details: Journal of clinical oncology, Vol.18(4), pp.877-877
Academic Unit: Miller School of Medicine; UMMG Department of Otolaryngology
Language: English
Resource Type: Journal article
PMID: 10673531
Record Identifier: 991031559672702976